Ocean Biomedical Overview
Latest ROE for Ocean Biomedical: 26.56% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow26.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for OCEA is 26.56%. That is above the sector sector average of 11.73%. Investors often review this figure alongside Ocean Biomedical's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, OCEA currently prints 26.56% for ROE, while the sector average sits near 11.73%. That is roughly 126.3% above the sector mean. Large gaps often invite a closer look at Ocean Biomedical's growth, margins, and balance sheet.
Return on Equity shows how effectively Ocean Biomedical converts resources into returns. At 26.56%, OCEA may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting OCEA's ROE (26.56%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
